- Home
- GMED vs ASND Comparison
GMED vs ASND Comparison
Compare GMED & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMED
- ASND
- Stock Information
- Founded
- GMED 2003
- ASND 2006
- Country
- GMED United States
- ASND Denmark
- Employees
- GMED N/A
- ASND N/A
- Industry
- GMED Medical/Dental Instruments
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- GMED Health Care
- ASND Health Care
- Exchange
- GMED Nasdaq
- ASND Nasdaq
- Market Cap
- GMED N/A
- ASND 9.1B
- IPO Year
- GMED 2012
- ASND 2015
- Fundamental
- Price
- GMED $71.01
- ASND $165.05
- Analyst Decision
- GMED Buy
- ASND Strong Buy
- Analyst Count
- GMED 13
- ASND 15
- Target Price
- GMED $96.91
- ASND $202.00
- AVG Volume (30 Days)
- GMED 1.3M
- ASND 506.0K
- Earning Date
- GMED 05-08-2025
- ASND 05-01-2025
- Dividend Yield
- GMED N/A
- ASND N/A
- EPS Growth
- GMED N/A
- ASND N/A
- EPS
- GMED 0.75
- ASND N/A
- Revenue
- GMED $2,519,355,000.00
- ASND $376,478,932.00
- Revenue This Year
- GMED $8.52
- ASND $61.43
- Revenue Next Year
- GMED $6.73
- ASND $73.07
- P/E Ratio
- GMED $94.68
- ASND N/A
- Revenue Growth
- GMED 60.62
- ASND 36.34
- 52 Week Low
- GMED $49.33
- ASND $111.09
- 52 Week High
- GMED $94.93
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- GMED 43.99
- ASND 62.95
- Support Level
- GMED $70.34
- ASND $152.07
- Resistance Level
- GMED $74.34
- ASND $159.14
- Average True Range (ATR)
- GMED 3.39
- ASND 10.95
- MACD
- GMED 0.25
- ASND 1.28
- Stochastic Oscillator
- GMED 53.31
- ASND 99.11
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.